Cnb Bank Leap Therapeutics, Inc. Transaction History

Cnb Bank

  • $215 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.42 - $9.18 $5,040 - $110,160
12,000 Added 300.0%
16,000 $7,000
Q2 2022

Aug 10, 2022
BUY
$0.96 - $1.91 $960 - $1,910
1,000 Added 33.33%
4,000 $5,000
Q1 2022

Apr 13, 2022
BUY
$1.6 - $3.35 $1,600 - $3,350
1,000 Added 50.0%
3,000 $5,000
Q4 2021

Jan 31, 2022
BUY
$2.08 - $3.65 $4,160 - $7,300
2,000 New
2,000 $6,000

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $344M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Cnb Bank Portfolio

Follow Cnb Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email